-
1
-
-
0031729399
-
Prion diseases in man
-
Ironside JW. Prion Diseases In Man. Journal of Pathology 186(3):227-234; 1998.
-
(1998)
Journal of Pathology
, vol.186
, Issue.3
, pp. 227-234
-
-
Ironside, J.W.1
-
2
-
-
0027997387
-
Prion protein is necessary for normal synaptic function
-
Collinge J, Whittington MA, Sidle KC, et al. Prion Protein Is Necessary For Normal Synaptic Function. Nature 370(6487):295-297; 1994.
-
(1994)
Nature
, vol.370
, Issue.6487
, pp. 295-297
-
-
Collinge, J.1
Whittington, M.A.2
Sidle, K.C.3
-
3
-
-
0033570367
-
Evidence of presynaptic location and function of the prion protein
-
Herms J, Tings T, Gall S, et al. Evidence Of Presynaptic Location And Function Of The Prion Protein. Journal of Neuroscience 19(20):8866-8875; 1999.
-
(1999)
Journal of Neuroscience
, vol.19
, Issue.20
, pp. 8866-8875
-
-
Herms, J.1
Tings, T.2
Gall, S.3
-
4
-
-
0033215478
-
Ataxia in prion protein deficient mice is associated with upregulation of the novel PrP - Like protein doppel
-
Moore RC, Lee IY, Silverman GL, et al. Ataxia In Prion Protein Deficient Mice Is Associated With Upregulation Of The Novel PrP - Like Protein Doppel. Journal of Molecular Biology 292(4):797-817; 1999.
-
(1999)
Journal of Molecular Biology
, vol.292
, Issue.4
, pp. 797-817
-
-
Moore, R.C.1
Lee, I.Y.2
Silverman, G.L.3
-
5
-
-
0032169565
-
Prion protein and superoxide dismutase activity
-
Brown DR, Besinger A. Prion Protein And Superoxide Dismutase Activity. Biochemical Journal 334:423-429; 1998.
-
(1998)
Biochemical Journal
, vol.334
, pp. 423-429
-
-
Brown, D.R.1
Besinger, A.2
-
6
-
-
0031194455
-
Prion protein deficient cells show altered response to oxidative stress due to decreased SOD -1 activity
-
Brown DR, Schulz-Schaeffer WJ, Schmidt B, Kretzschmar HA. Prion Protein Deficient Cells Show Altered Response To Oxidative Stress Due To Decreased SOD -1 Activity. Experimental Neurology 146(1):104-112; 1997.
-
(1997)
Experimental Neurology
, vol.146
, Issue.1
, pp. 104-112
-
-
Brown, D.R.1
Schulz-Schaeffer, W.J.2
Schmidt, B.3
Kretzschmar, H.A.4
-
7
-
-
0034963098
-
Marked increase of neuronal prion protein immunoreactivity in alzheimer's disease and human prion diseases
-
Voigtlander T, Kloppel S, Birner P, et al. Marked Increase Of Neuronal Prion Protein Immunoreactivity In Alzheimer's Disease And Human Prion Diseases. Acta Neuropathologica 101(5):417-423; 2001.
-
(2001)
Acta Neuropathologica
, vol.101
, Issue.5
, pp. 417-423
-
-
Voigtlander, T.1
Kloppel, S.2
Birner, P.3
-
8
-
-
0035141524
-
Prion protein expression in senile plaques in Alzheimer's disease
-
Ferrer I, Blanco R, Carmona M, et al. Prion Protein Expression In Senile Plaques In Alzheimer's Disease. Acta Neuropathologica 101(1):49-56; 2001.
-
(2001)
Acta Neuropathologica
, vol.101
, Issue.1
, pp. 49-56
-
-
Ferrer, I.1
Blanco, R.2
Carmona, M.3
-
9
-
-
0028931965
-
SSCP analysis and sequencing of the prion protein gene detects two 24 bp deletions in an atypical Alzheimer's disease family
-
Perry RT, Go RCP, Harrell LE, et al. SSCP Analysis And Sequencing Of The Prion Protein Gene Detects Two 24 bp Deletions In An Atypical Alzheimer's Disease Family. American Journal of Medical Genetics 60(1):12-18; 1995.
-
(1995)
American Journal of Medical Genetics
, vol.60
, Issue.1
, pp. 12-18
-
-
Perry, R.T.1
Go, R.C.P.2
Harrell, L.E.3
-
10
-
-
0034913977
-
Prion protein gene polymorphism and Alzheimer's disease: One modulatory trait of cognitive decline?
-
Casadei VM, Ferri C, Calabrese E, et al. Prion Protein Gene Polymorphism And Alzheimer's Disease: One Modulatory Trait of Cognitive Decline? Journal of Neurology, Neurosurgery and Psychiatry 71(2):279-280; 2001
-
(2001)
Journal of Neurology, Neurosurgery and Psychiatry
, vol.71
, Issue.2
, pp. 279-280
-
-
Casadei, V.M.1
Ferri, C.2
Calabrese, E.3
-
11
-
-
85136388962
-
Early onset familial alzheimer disease with co-existing -amyloid and prion pathology
-
Leuba G, Saini K, Savioz A, Charnay Y. Early Onset Familial Alzheimer Disease With Co-existing -Amyloid And Prion Pathology. Journal of the American Medical Association 283(13):756; 2000.
-
(2000)
Journal of the American Medical Association
, vol.283
, Issue.13
, pp. 756
-
-
Leuba, G.1
Saini, K.2
Savioz, A.3
Charnay, Y.4
-
13
-
-
0030898724
-
An assessment of oxidative damage to proteins, lipids, and dna in brain from patients with alzheimer's disease
-
Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B. An Assessment Of Oxidative Damage To Proteins, Lipids, And DNA In Brain From Patients With Alzheimer's Disease. Journal of Neurochemistry 68(5):2061-2069; 1997.
-
(1997)
Journal of Neurochemistry
, vol.68
, Issue.5
, pp. 2061-2069
-
-
Lyras, L.1
Cairns, N.J.2
Jenner, A.3
Jenner, P.4
Halliwell, B.5
-
14
-
-
0032429784
-
Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses
-
Yatin SM, Aksenova M, Aksenov M, et al. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses. Journal of Molecular Neuroscience 11(3):183-97; 1998.
-
(1998)
Journal of Molecular Neuroscience
, vol.11
, Issue.3
, pp. 183-197
-
-
Yatin, S.M.1
Aksenova, M.2
Aksenov, M.3
-
15
-
-
0042328239
-
Overexpression of SOD-1 protects against -amyloid peptide toxicity: Effect of oestrogen and copper chelators
-
Celsi F, Ferri A, Casciati A, et al. Overexpression of SOD-1 Protects Against -Amyloid Peptide Toxicity: Effect of Oestrogen and Copper Chelators. Neurochemistry International 44(1):25-33; 2004.
-
(2004)
Neurochemistry International
, vol.44
, Issue.1
, pp. 25-33
-
-
Celsi, F.1
Ferri, A.2
Casciati, A.3
-
16
-
-
0034767752
-
In situ hybridisation analysis of PrP mRNA in human CNS tissue
-
McLennan NF, Rennison KA, Bell JE, Ironside JW. In Situ Hybridisation Analysis Of PrP mRNA In Human CNS Tissue. Neuropath. Applied Neurobiology 27(5):373-383; 2001.
-
(2001)
Neuropath. Applied Neurobiology
, vol.27
, Issue.5
, pp. 373-383
-
-
McLennan, N.F.1
Rennison, K.A.2
Bell, J.E.3
Ironside, J.W.4
-
17
-
-
0027374785
-
Alzheimer's disease and creutzfeldt-jakob disease: Overlap of pathogenic mechanisms
-
DeArmond SJ. Alzheimer's Disease and Creutzfeldt-Jakob Disease: Overlap Of Pathogenic Mechanisms. Currents Opinions in Neurology 6(6):872-881; 1993.
-
(1993)
Currents Opinions in Neurology
, vol.6
, Issue.6
, pp. 872-881
-
-
DeArmond, S.J.1
-
18
-
-
0031847332
-
Coexistance of Alzheimer-type neuropathology in creutzfeldt jakob disease
-
Hainfellner JA, Wanschitz J, Jellinger K, Liberski PP, Gullotta F, Budka H. Coexistance Of Alzheimer-Type Neuropathology In Creutzfeldt Jakob Disease. Acta Neuropathologica 96(2):116-122; 1998.
-
(1998)
Acta Neuropathologica
, vol.96
, Issue.2
, pp. 116-122
-
-
Hainfellner, J.A.1
Wanschitz, J.2
Jellinger, K.3
Liberski, P.P.4
Gullotta, F.5
Budka, H.6
-
19
-
-
0030198517
-
Amyloid in alzheimer's disease and prion related encephalopathies: Studies with synthetic peptides
-
Forloni G, Tagliavini F, Bugiani O, Salmona M. Amyloid in Alzheimer's Disease And Prion Related Encephalopathies: Studies With Synthetic Peptides. Progress in Neurobiology 49(4):287-315; 1996.
-
(1996)
Progress in Neurobiology
, vol.49
, Issue.4
, pp. 287-315
-
-
Forloni, G.1
Tagliavini, F.2
Bugiani, O.3
Salmona, M.4
-
21
-
-
0037031611
-
The prion protein in human neurodegenerative disorders
-
Kovacs GG, Zerbi P, Voigtlander T, et al. The Prion Protein In Human Neurodegenerative Disorders. Neuroscience Letters 329(3):269-272; 2002.
-
(2002)
Neuroscience Letters
, vol.329
, Issue.3
, pp. 269-272
-
-
Kovacs, G.G.1
Zerbi, P.2
Voigtlander, T.3
|